Piramal Pharma
BSE: 543635 | NSE: PPLPHARMA | ISIN: INE0DK501011 | SECTOR: Biotechnology & DrugsOpen
126.50High
127.85Low
125.65Prev Close
125.95P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
166.65BVolume
182.90KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
126.45
Company Description
- Biotechnology & Drugs
BSE
543635NSE
PPLPHARMAISIN
INE0DK501011
Piramal Pharma Limited is an India-based pharmaceutical company, which offers a portfolio of differentiated pharma products across a domestic and global distribution network. The Company has approximately 17 global facilities and a global distribution network in over 100 countries. The Company's subsidiaries include Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business, and the India consumer healthcare business selling over-the-counter products. PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to generic companies. PCC's complex hospital product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain, anesthetics, injectable anti-infectives, and other therapies.
Company Officers
Nandini Piramal
Executive Chairman of the BoardVivek Valsaraj
Chief Financial Officer, Executive DirectorTanya Sanish
Compliance Officer, Company SecretaryPeter Deyoung
Executive Director, Chief Executive Officer, Global Pharma